HRP20031055B1 - Novel immunomodulating compounds - Google Patents

Novel immunomodulating compounds

Info

Publication number
HRP20031055B1
HRP20031055B1 HR20031055A HRP20031055A HRP20031055B1 HR P20031055 B1 HRP20031055 B1 HR P20031055B1 HR 20031055 A HR20031055 A HR 20031055A HR P20031055 A HRP20031055 A HR P20031055A HR P20031055 B1 HRP20031055 B1 HR P20031055B1
Authority
HR
Croatia
Prior art keywords
alkyl
halo
lower alkyl
alkoxy
unsaturated
Prior art date
Application number
HR20031055A
Other languages
English (en)
Croatian (hr)
Inventor
Axel Bj�rk Per
Fex Tomas
Olof Lars
Poul Sorensen
Da Graca Thrige Dorthe
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of HRP20031055A2 publication Critical patent/HRP20031055A2/hr
Publication of HRP20031055B1 publication Critical patent/HRP20031055B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20031055A 2001-07-04 2003-12-17 Novel immunomodulating compounds HRP20031055B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102404A SE0102404D0 (sv) 2001-07-04 2001-07-04 Novel immunomodulating compounds
PCT/SE2002/001309 WO2003004495A1 (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds

Publications (2)

Publication Number Publication Date
HRP20031055A2 HRP20031055A2 (en) 2004-06-30
HRP20031055B1 true HRP20031055B1 (en) 2008-01-31

Family

ID=20284743

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20031055A HRP20031055B1 (en) 2001-07-04 2003-12-17 Novel immunomodulating compounds

Country Status (21)

Country Link
EP (1) EP1409485B1 (de)
JP (1) JP2005501033A (de)
CN (1) CN1249063C (de)
AT (1) ATE324373T1 (de)
AU (1) AU2002315996B2 (de)
BR (1) BR0210776A (de)
CA (1) CA2451749A1 (de)
DE (1) DE60210977T2 (de)
ES (1) ES2258150T3 (de)
HK (1) HK1066809A1 (de)
HR (1) HRP20031055B1 (de)
HU (1) HUP0401204A3 (de)
MX (1) MXPA04000017A (de)
NO (1) NO20035684L (de)
NZ (1) NZ530316A (de)
PL (1) PL367637A1 (de)
RU (1) RU2004103079A (de)
SE (1) SE0102404D0 (de)
WO (1) WO2003004495A1 (de)
YU (1) YU101603A (de)
ZA (1) ZA200309806B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1813616B1 (de) 2002-11-22 2013-03-27 Active Biotech AB Pyrazoloquinoline mit immunmodulierender Aktivität
DE60326639D1 (de) * 2002-12-16 2009-04-23 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
GB0305876D0 (en) * 2003-03-14 2003-04-16 Avidex Ltd Immuno inhibitory heterocyclic compounds
US7276505B2 (en) 2003-03-14 2007-10-02 Medigene Limited Immunomodulating heterocyclic compounds
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
WO2005068467A1 (ja) 2004-01-14 2005-07-28 Ajinomoto Co., Inc. 新規縮環化合物
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
WO2006016093A1 (en) * 2004-08-09 2006-02-16 Avidex Limited Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
CN101863903B (zh) * 2010-06-08 2014-03-12 沈阳药科大学 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用
EP3013832B1 (de) * 2013-06-24 2020-11-04 Merck Patent GmbH Pyrazoleverbindungen als modulatoren des fshr und ihre verwendung
EP2883883A1 (de) 2013-12-16 2015-06-17 Cardio3 Biosciences S.A. Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden
EA035074B9 (ru) 2014-07-08 2020-05-15 Авертана Лимитед Извлечение продукции из титансодержащих минералов

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
EP0354693A1 (de) * 1988-08-09 1990-02-14 The Boots Company PLC Therapeutische Mittel
EP0354694A1 (de) * 1988-08-09 1990-02-14 The Boots Company PLC Therapeutische [1]Benzothiopyrano[4,3-c]pyrazole
WO1991006298A1 (en) * 1989-10-26 1991-05-16 Kabi Pharmacia Therapeutics Ab New use of condensed quinoline compound
WO1991011448A1 (en) * 1990-02-02 1991-08-08 The Boots Company Plc Therapeutic agents
WO1997034893A1 (en) * 1996-03-20 1997-09-25 Astra Pharmaceuticals Ltd. Pharmaceutically useful compounds

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
EP0354693A1 (de) * 1988-08-09 1990-02-14 The Boots Company PLC Therapeutische Mittel
EP0354694A1 (de) * 1988-08-09 1990-02-14 The Boots Company PLC Therapeutische [1]Benzothiopyrano[4,3-c]pyrazole
WO1991006298A1 (en) * 1989-10-26 1991-05-16 Kabi Pharmacia Therapeutics Ab New use of condensed quinoline compound
WO1991011448A1 (en) * 1990-02-02 1991-08-08 The Boots Company Plc Therapeutic agents
WO1997034893A1 (en) * 1996-03-20 1997-09-25 Astra Pharmaceuticals Ltd. Pharmaceutically useful compounds

Also Published As

Publication number Publication date
RU2004103079A (ru) 2005-06-10
JP2005501033A (ja) 2005-01-13
DE60210977D1 (de) 2006-06-01
WO2003004495A1 (en) 2003-01-16
YU101603A (en) 2006-05-25
BR0210776A (pt) 2004-07-20
EP1409485B1 (de) 2006-04-26
ES2258150T3 (es) 2006-08-16
NO20035684L (no) 2004-03-02
EP1409485A1 (de) 2004-04-21
CN1249063C (zh) 2006-04-05
HUP0401204A3 (en) 2008-03-28
HUP0401204A2 (hu) 2004-10-28
HRP20031055A2 (en) 2004-06-30
AU2002315996B2 (en) 2007-11-29
CA2451749A1 (en) 2003-01-16
ZA200309806B (en) 2004-12-20
PL367637A1 (en) 2005-03-07
HK1066809A1 (en) 2005-04-01
NO20035684D0 (no) 2003-12-19
NZ530316A (en) 2004-08-27
ATE324373T1 (de) 2006-05-15
DE60210977T2 (de) 2006-09-21
MXPA04000017A (es) 2004-05-21
CN1522254A (zh) 2004-08-18
SE0102404D0 (sv) 2001-07-04

Similar Documents

Publication Publication Date Title
ATE225348T1 (de) Substituierte azaindolylidenderivate und verfahren zu ihrer herstellung
CA2184919A1 (en) New Piperazine Derivatives and Methods for the Preparation Thereof and Compositions Containing the Same
DE60209497D1 (de) Schmierölzusammensetzung enthaltend ein gemisch aus carboxylsäuren und aminen als rostschutzmittel
IL154893A0 (en) Aliphatic nitrogen-containing cyclic compounds, methods for the preparation thereof and pharmaceutical compositions containing the same
HRP20031055B1 (en) Novel immunomodulating compounds
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
EP0353955A3 (de) Chemische Verbindungen
WO2000027815A3 (en) N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
HUT70506A (en) Pyridinecarboximidamide compounds, pharmaceutical compositions containing them and process for producing them
CA2345673A1 (en) Composition and process for removal of acid gases
EP0997462A4 (de) Naphthyridinderivate oder salze davon
DE69939602D1 (de) Verbindungen, aus der verbindung hergestelltes polymer und das polymer enthaltende mischung
EP0351385A3 (de) Amidino- und Guanidino-Derivate
WO1997031016A3 (en) New inhibitors of sh2-mediated processes
CA2168764A1 (en) Novel Quinolone Carboxylic Acid Derivatives
WO1998053790A3 (en) Compounds that inhibit the binding of vascular endothelial growth factor to its receptors
WO2001051004A3 (en) Anti-cancer agent containing naphthoquinone compound
DK0968189T3 (da) Fremgangsmåde til fremstilling af nicotinsyrer
MY136065A (en) Prodrugs to nmda receptor ligands
TW222273B (de)
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
HRP20050242B1 (en) Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
PL339966A1 (en) Novel 1-aza-2-alkyl-6-arylcycloalkane compounds, method of obtaining them and pharmacological compositions containing them
CA2123890A1 (en) Novel Sulfonic Acid Derivative and Medicinal Use Thereof
HRP20030712B1 (en) Caloporoside derivatives, methods for the production thereof and their use

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080624

Year of fee payment: 7

PBON Lapse due to non-payment of renewal fee

Effective date: 20090703